XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.1

Moderna Collaboration and License Agreement (Tables)

3 Months Ended

Mar. 31, 2023

Moderna Collaboration and License Agreement

Schedule of estimated revenue expected to be recognized in the future related to performance obligations

​	​	​	​
​		Transaction
​	​	price unsatisfied
Performance obligations:		​
Research and development	​	$	61,376
Option rights	​		45,000
Total performance obligations	​	$	106,376

Summary of changes in deferred revenue

​

​	​	​	​	​	​	​
​	​	Three months ended March 31,
​		2023			2022
Balance at the beginning of the period	​	$	47,459	​	$	—
Deferral of revenue	​		2,920	​		46,441
Recognition of unearned revenue	​		(3,243)	​		(822)
Balance at the end of the period	​	$	47,136	​	$	45,619

​

X

- Definition

Tabular disclosure of changes in deferred revenue.

+ References

No definition available.

+ Details

Name:	carm_ScheduleOfChangesInDeferredRevenueTableTextBlock
Namespace Prefix:	carm_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of expected timing for satisfying remaining performance obligation.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(1)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045

+ Details

Name:	us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration